Orser Capital Management LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Orser Capital Management LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,421 shares of the medical equipment provider's stock, valued at approximately $1,199,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. RFG Advisory LLC boosted its stake in shares of Intuitive Surgical by 309.4% in the 1st quarter. RFG Advisory LLC now owns 3,238 shares of the medical equipment provider's stock worth $1,604,000 after buying an additional 2,447 shares during the last quarter. Capital Asset Advisory Services LLC lifted its holdings in Intuitive Surgical by 6.3% in the first quarter. Capital Asset Advisory Services LLC now owns 6,807 shares of the medical equipment provider's stock valued at $3,451,000 after acquiring an additional 401 shares during the period. Fulton Bank N.A. boosted its position in Intuitive Surgical by 0.6% in the first quarter. Fulton Bank N.A. now owns 3,802 shares of the medical equipment provider's stock worth $1,883,000 after purchasing an additional 24 shares during the last quarter. HBW Advisory Services LLC grew its stake in shares of Intuitive Surgical by 11.1% during the 1st quarter. HBW Advisory Services LLC now owns 542 shares of the medical equipment provider's stock valued at $268,000 after purchasing an additional 54 shares during the period. Finally, ST Germain D J Co. Inc. increased its position in shares of Intuitive Surgical by 69.8% during the 1st quarter. ST Germain D J Co. Inc. now owns 73 shares of the medical equipment provider's stock valued at $36,000 after purchasing an additional 30 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Citigroup reiterated a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Piper Sandler reduced their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Barclays decreased their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Finally, Truist Financial cut their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $596.05.

Intuitive Surgical Stock Down 0.2%

NASDAQ ISRG traded down $0.98 during trading hours on Friday, reaching $557.08. The company's stock had a trading volume of 1,103,774 shares, compared to its average volume of 1,641,815. Intuitive Surgical, Inc. has a 1 year low of $413.52 and a 1 year high of $616.00. The company has a market capitalization of $199.67 billion, a price-to-earnings ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67. The firm's 50-day moving average price is $521.99 and its 200-day moving average price is $539.26.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the firm earned $1.50 earnings per share. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president now owns 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the firm's stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares of the company's stock, valued at approximately $2,793,033.06. The trade was a 60.72% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 25,443 shares of company stock worth $12,692,195. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.